N-Cyclobutyl-N-((2,2-dimethyl-2H-pyrano[3,2-b]pyridin-6-yl)methyl)-3,4-dimethoxybenzenesulfonamide

ID: ALA1940227

Chembl Id: CHEMBL1940227

Cas Number: 1342890-83-8

PubChem CID: 54575622

Max Phase: Preclinical

Molecular Formula: C23H28N2O5S

Molecular Weight: 444.55

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(S(=O)(=O)N(Cc2ccc3c(n2)C=CC(C)(C)O3)C2CCC2)cc1OC

Standard InChI:  InChI=1S/C23H28N2O5S/c1-23(2)13-12-19-20(30-23)10-8-16(24-19)15-25(17-6-5-7-17)31(26,27)18-9-11-21(28-3)22(14-18)29-4/h8-14,17H,5-7,15H2,1-4H3

Standard InChI Key:  CQGIUFASDNXPRB-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

Associated Targets(Human)

HIF1A Tchem Hypoxia inducible factors; HIF-1-alpha, HIF-2-alpha (820 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HIF1A Tchem Hypoxia-inducible factor 1 alpha (6027 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EP300 Tchem Histone acetyltransferase p300/Hypoxia-inducible factor 1-alpha (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 444.55Molecular Weight (Monoisotopic): 444.1719AlogP: 4.03#Rotatable Bonds: 7
Polar Surface Area: 77.96Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.66CX LogP: 3.34CX LogD: 3.34
Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.64Np Likeness Score: -0.41

References

1. Mooring SR, Jin H, Devi NS, Jabbar AA, Kaluz S, Liu Y, Van Meir EG, Wang B..  (2011)  Design and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathway.,  54  (24): [PMID:22032632] [10.1021/jm201018g]
2. Ferguson J, De Los Santos Z, Devi N, Van Meir E, Zingales S, Wang B..  (2017)  Examining the structure-activity relationship of benzopyran-based inhibitors of the hypoxia inducible factor-1 pathway.,  27  (8): [PMID:28285917] [10.1016/j.bmcl.2017.02.073]
3. Li J, Xi W, Li X, Sun H, Li Y..  (2019)  Advances in inhibition of protein-protein interactions targeting hypoxia-inducible factor-1 for cancer therapy.,  27  (7): [PMID:30819620] [10.1016/j.bmc.2019.01.042]

Source